Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENERGY trial of trimetazidine in MYH7 mutation carriers
NL-OMON25078Recruiting
- Sponsor
- ZonMW en de Hartstichting, Programma Translationeel Onderzoek, project 95105003
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hypertrophic cardiomyopathy (HCM) comparing Trimetazidine with Placebo (2 arms). Primary endpoint: Myocardial energy efficiency. Started Feb 2019; status: recruiting.
02
Drugs
trimetazidine
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NL-OMON25078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25078.